作者:
Liu,Q. [1]
;
Tomei,S. [2]
;
Ascierto,M.L. [3]
;
DeGiorgi,V. [4]
;
Bedognetti,D. [5]
;
Dai,C. [6]
;
Uccellini,L. [7]
;
Spivey,T. [8]
;
Pos,Z. [9]
;
Thomas,J. [10]
;
Reinboth,J. ;
Murtas,D. ;
Zhang,Q. ;
Chouchane,L. ;
Weiss,G.R. ;
SlingluffJr.,C.L. ;
Lee,P.P. ;
Rosenberg,S.A. ;
Alter,H. ;
Yao,K. ;
Wang,E. ;
Marincola,F.M.
作者单位:
Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical
[1]
Rush Medical School, Chicago, IL, United States
[2]
MTA-SE 'Lendület,' Experimental and Translational Immunomics Research Group, Budapest, Hungary
[3]
Columbia University, New York, NY, United States
[4]
Surgery Branch, National Cancer Institute (NCI), Bethesda, MD, United States
[5]
University of Virginia Health Systems, Charlottesville, VI, United States
[6]
Cancer Immunotherapeutics and Tumor Immunology, City of Hope and Beckman Research Institute, Duarte
[7]
Weill Cornell Medical College in Qatar, Doha, Qatar
[8]
Cancer Research Institute, Southern Medical University, Guangzhou, China
[9]
Xiamen Heart Center, Zhongshan Hospital, Medical School of Xiamen University, Xiamen, Fujian, China
[10]
发布时间
2014-07-12